Jordan Julie has filed 18 insider transactions across 2 companies since August 2023.
Most recent transaction: a sale of 828 shares of Neurogene Inc. ($NGNE) on March 26, 2026.
Activity breakdown: 0 open-market purchases and 5 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 26, 2026 | Neurogene Inc. | $NGNE | Jordan Julie | Chief Medical Officer | S | Common Stock | 828 | $21.89 | 12,472.0000 | 21,168,431 | 6.23% | 0.00% |
| Feb. 20, 2026 | Neurogene Inc. | $NGNE | Jordan Julie | Chief Medical Officer | A | Stock Option (Right to Buy) | 29600 | $0.00 | 29,600.0000 | 21,168,431 | 9999.99% | 0.14% |
| Feb. 20, 2026 | Neurogene Inc. | $NGNE | Jordan Julie | Chief Medical Officer | A | Common Stock | 4900 | $0.00 | 13,300.0000 | 21,168,431 | 58.33% | 0.02% |
| March 26, 2025 | Neurogene Inc. | $NGNE | Jordan Julie | Chief Medical Officer | A | Common Stock | 8400 | $0.00 | 8,400.0000 | 17,567,082 | 9999.99% | 0.05% |
| March 26, 2025 | Neurogene Inc. | $NGNE | Jordan Julie | Chief Medical Officer | A | Employee Stock Option (Right to buy) | 50300 | $0.00 | 50,300.0000 | 17,567,082 | 9999.99% | 0.29% |
| Jan. 16, 2024 | Neurogene Inc. | $NGNE | Jordan Julie | Chief Medical Officer | A | Stock Option (Right to Buy) | 75000 | $0.00 | 75,000.0000 | 4,656,947 | 9999.99% | 1.61% |
| Aug. 3, 2023 | Q32 Bio Inc. | $QTTB | Jordan Julie | Chief Medical Officer | S | Common Stock | 109 | $1.39 | 4,160.0000 | 0 | 2.55% | 0.00% |
| Aug. 3, 2023 | Q32 Bio Inc. | $QTTB | Jordan Julie | Chief Medical Officer | M | Common Stock | 4644 | $0.00 | 8,804.0000 | 0 | 111.63% | 0.00% |
| Aug. 3, 2023 | Q32 Bio Inc. | $QTTB | Jordan Julie | Chief Medical Officer | S | Common Stock | 1308 | $1.39 | 7,496.0000 | 0 | 14.86% | 0.00% |
| Aug. 3, 2023 | Q32 Bio Inc. | $QTTB | Jordan Julie | Chief Medical Officer | M | Restricted Stock Units | 1548 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Aug. 3, 2023 | Q32 Bio Inc. | $QTTB | Jordan Julie | Chief Medical Officer | M | Restricted Stock Units | 387 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Aug. 3, 2023 | Q32 Bio Inc. | $QTTB | Jordan Julie | Chief Medical Officer | S | Common Stock | 436 | $1.39 | 3,882.0000 | 0 | 10.10% | 0.00% |
| Aug. 3, 2023 | Q32 Bio Inc. | $QTTB | Jordan Julie | Chief Medical Officer | M | Restricted Stock Units | 4644 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Aug. 3, 2023 | Q32 Bio Inc. | $QTTB | Jordan Julie | Chief Medical Officer | M | Common Stock | 1548 | $0.00 | 4,318.0000 | 0 | 55.88% | 0.00% |
| Aug. 3, 2023 | Q32 Bio Inc. | $QTTB | Jordan Julie | Chief Medical Officer | M | Common Stock | 387 | $0.00 | 4,269.0000 | 0 | 9.97% | 0.00% |
| Aug. 2, 2023 | Q32 Bio Inc. | $QTTB | Jordan Julie | Chief Medical Officer | M | Common Stock | 350 | $0.00 | 2,869.0000 | 0 | 13.89% | 0.00% |
| Aug. 2, 2023 | Q32 Bio Inc. | $QTTB | Jordan Julie | Chief Medical Officer | S | Common Stock | 99 | $1.31 | 2,770.0000 | 0 | 3.45% | 0.00% |
| Aug. 2, 2023 | Q32 Bio Inc. | $QTTB | Jordan Julie | Chief Medical Officer | M | Restricted Stock Units | 350 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |